The progress in our understanding of CIN in breast cancer research

por Liao, Yu-Yang, Cao, Wen-Ming
Publicado 2023

Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China

por Cao, Wen-Ming, Gao, Yun, Wang, Xiao-Jia
Publicado 2015

The role of TSC2 in breast cancer: a literature review

por Zhu, Qiao-Yan, He, Zhe-Min, Cao, Wen-Ming, Li, Bei
Publicado 2023

BRCA1 Reversion Mutation Confers Resistance to Olaparib and Camrelizumab in a Patient with Breast Cancer Liver Metastasis

por Pan, Jia-Ni, Lei, Lei, Ye, Wei-Wu, Wang, Xiao-Jia, Cao, Wen-Ming
Publicado 2021

High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer

por Zhu, Liang, Pan, Jia-Ni, Qian, Ziliang, Ye, Wei-Wu, Wang, Xiao-Jia, Cao, Wen-Ming
Publicado 2021

TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells

por Wang, Zhenyu, Zhang, Huiyuan, Shi, Minghao, Yu, Yang, Wang, Hao, Cao, Wen-Ming, Zhao, Yanling, Zhang, Hong
Publicado 2016

Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer

por Yang, Ziyan, Feng, Jianguo, Jing, Ji, Huang, Yuan, Ye, Wei-Wu, Lei, Lei, Wang, Xiao-Jia, Cao, Wen-Ming
Publicado 2023

Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis

por Wang, Hao, Yu, Yang, Jiang, Zheng, Cao, Wen-Ming, Wang, Zhenyu, Dou, Jun, Zhao, Yanling, Cui, Yunfu, Zhang, Hong
Publicado 2016

Non-Invasive Biomarkers for Early Detection of Breast Cancer

por Li, Jiawei, Guan, Xin, Fan, Zhimin, Ching, Lai-Ming, Li, Yan, Wang, Xiaojia, Cao, Wen-Ming, Liu, Dong-Xu
Publicado 2020

Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study

por Shen, Xia-Bo, Li, Guang-Liang, Zheng, Ya-Bing, Chen, Zhan-Hong, Cao, Wen-Ming, Wang, Xiao-Jia, Shao, Xi-Ying
Publicado 2021

Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2− Breast Cancer Patient With High Tumor Mutational Burden

por Wang, Rong, Yang, Yuchen, Ye, Wei-Wu, Xiang, Jianxing, Chen, Songan, Zou, Wei-Bin, Wang, Xiao-Jia, Chen, Tianhui, Cao, Wen-Ming
Publicado 2021

Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer

por Cao, Wen-Ming, Gao, Yun, Yang, Hong-Jian, Xie, Shang-Nao, Ding, Xiao-Wen, Pan, Zhi-Wen, Ye, Wei-Wu, Wang, Xiao-Jia
Publicado 2016

Decoding the dynamic DNA methylation and hydroxymethylation landscapes in endodermal lineage intermediates during pancreatic differentiation of hESC

por Li, Jia, Wu, Xinwei, Zhou, Yubin, Lee, Minjung, Guo, Lei, Han, Wei, Mo, William, Cao, Wen-ming, Sun, Deqiang, Xie, Ruiyu, Huang, Yun
Publicado 2018

Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients

por Zong, Hong, Zhang, Jian, Xu, Zhengyang, Pan, Jia-Ni, Wang, Rong, Han, Jinming, Jiang, Miao, Ren, Ruiping, Zang, Li, Wang, Haitao, Cao, Wen-Ming
Publicado 2022

Deleterious Mutations in DNA Repair Gene FANCC Exist in BRCA1/2-Negative Chinese Familial Breast and/or Ovarian Cancer Patients

por Pan, Zhi-Wen, Wang, Xiao-Jia, Chen, Tianhui, Ding, Xiao-Wen, Jiang, Xiyi, Gao, Yun, Mo, Wen-Ju, Huang, Yuan, Lou, Cai-Jin, Cao, Wen-Ming
Publicado 2019

Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women

por Cao, Wen-Ming, Zheng, Ya-Bing, Gao, Yun, Ding, Xiao-Wen, Sun, Yan, Huang, Yuan, Lou, Cai-Jin, Pan, Zhi-Wen, Peng, Guang, Wang, Xiao-Jia
Publicado 2019

Differences in the clinicopathological characteristics of pure and mixed invasive micropapillary breast carcinomas from eastern China

por Wang, Rong, Li, Nani, Wang, Xiao-Jia, Chen, Tianhui, Zhang, Hong, Cheng, Yongran, Sun, Wenyong, Chen, Zhanhong, Zheng, Yabing, Lizaso, Analyn, Chen, Songan, Cao, Wen-Ming
Publicado 2021

Profiling Receptor Tyrosine Kinase Fusions in Chinese Breast Cancers

por Tao, Zhonghua, Liu, Jianxia, Li, Ting, Xu, Hong, Chen, Kai, Zhang, Jian, Zhou, Hao, Sun, Jie, Han, Jinming, Guo, Zhaoji, Yang, Hua, Cao, Wen-Ming, Hu, Xichun
Publicado 2021

A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer

por Zhu, Qiao-Yan, Li, Pu-Chun, Zhu, Yi-Fan, Pan, Jia-Ni, Wang, Rong, Li, Xiao-Lin, Ye, Wei-Wu, Ding, Xiao-Wen, Wang, Xiao-Jia, Cao, Wen-Ming
Publicado 2023

FOXK2 amplification and overexpression promotes breast cancer development and chemoresistance

por Yu, Yang, Cao, Wen-Ming, Cheng, Feng, Shi, Zhongcheng, Han, Lili, Yi, Jin-Ling, da Silva, Edaise M, Dopeso, Higinio, Chen, Hui, Yang, Jianhua, Wang, Xiaosong, Zhang, Chunchao, Zhang, Hong
Publicado 2023